Medifast, Inc. (MED) Tops Q4 EPS by 3c; Issues Mixed Outlook
Tweet
Share
E-mailGet Alerts MED Hot Sheet
Price: $11.71 +1.04%
Financial Fact:
Nonoperating Income (Expense), Total: 58K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Nonoperating Income (Expense), Total: 58K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Medifast, Inc. (NYSE: MED) reported Q4 EPS of $0.28, $0.03 better than the analyst estimate of $0.25. Revenue for the quarter came in at $83.2 million versus the consensus estimate of $82.9 million.
Medifast, Inc. sees Q1 2013 EPS of $0.32-0.35, versus the consensus of $0.45. Medifast, Inc. sees Q1 2013 revenue of $93-95 million, versus the consensus of $101.13 million.
Medifast, Inc. sees FY2013 EPS of $1.70-1.80, versus the consensus of $1.76. Medifast, Inc. sees FY2013 revenue of $385-400 million, versus the consensus of $399.6 million.
For earnings history and earnings-related data on Medifast, Inc. (MED) click here.
Medifast, Inc. sees Q1 2013 EPS of $0.32-0.35, versus the consensus of $0.45. Medifast, Inc. sees Q1 2013 revenue of $93-95 million, versus the consensus of $101.13 million.
Medifast, Inc. sees FY2013 EPS of $1.70-1.80, versus the consensus of $1.76. Medifast, Inc. sees FY2013 revenue of $385-400 million, versus the consensus of $399.6 million.
For earnings history and earnings-related data on Medifast, Inc. (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
- Boxlight Corporation (BOXL) Tops Q2 EPS by 2050c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
